SCHEMBL21822134

SCHEMBL21822134

CC(C)(C)OC(=O)NC1CCC(OC(=O)c2cc3ccc(C#N)cc3n2Cc2cccc3ccccc23)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.42
▸ DPP4 P27487 1/20 0.41
▸ CTSS P25774 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ CCR9 P51686 2/20 0.39
▸ DRD3 P35462 2/20 0.37
▸ KCNA3 P22001 1/20 0.37
▸ AAK1 Q2M2I8 1/20 0.37
▸ KDM4D Q6B0I6 3/20 0.37
▸ XIAP P98170 1/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ NSD2 O96028 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ CACNB4 O00305 1/20 0.35
▸ CACNA1A O00555 1/20 0.35
▸ CACNA1G O43497 1/20 0.35
▸ CACNG3 O60359 1/20 0.35
▸ CACNA1F O60840 1/20 0.35
▸ CACNA1H O95180 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28575236 0.91 DRD2 (0.44) DRD2DPP4CTSSCTSKCCR9
SCHEMBL28575235 0.91 DRD2 (0.44) DRD2DPP4CTSSCTSKCCR9
SCHEMBL30180715 0.86 DRD2 (0.40) DRD2DPP4CTSSCTSKCCR9
SCHEMBL28580759 0.86 DRD2 (0.40) DRD2DPP4CTSSCTSKCCR9
SCHEMBL28580762 0.86 DRD2 (0.40) DRD2DPP4CTSSCTSKCCR9
SCHEMBL30180863 0.86 EPHX1 (0.36) DRD2DPP4CTSSCTSKEPHX1
SCHEMBL25017972 0.85 F10 (0.35) DRD2DPP4EPHX1CACNB4CACNA1A
SCHEMBL28588251 0.84 DRD2 (0.42) DRD2DPP4CTSSCTSKDRD3
SCHEMBL28588250 0.84 DRD2 (0.42) DRD2DPP4CTSSCTSKDRD3
SCHEMBL28575220 0.82 DRD2 (0.41) DRD2DPP4CTSSCTSKDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed
EP-3860636-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF Disc Medicine, Inc. (US) 2021-08-11 — — EP disclosed
CN-112996529-A Matriptase 2 inhibitor and application thereof 迪斯克医药公司 2021-06-18 — — CN disclosed
WO-2020072580-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. (US) 2020-04-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 DRD2 4828/4885DPP4 67/4885CTSS 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback